Ying Jiao

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Bacteroides acidifaciens enriched by KRAS mutation promotes colorectal tumorigenesis.

Bacteroides acidifaciens enriched by KRAS mutation promotes colorectal tumorigenesis.

Journal: Cell host & microbe

Published: February 14, 2026

ADAT2-mediated A-to-I tRNA modification promotes oncogenic translation and colorectal cancer progression and chemoresistance.

ADAT2-mediated A-to-I tRNA modification promotes oncogenic translation and colorectal cancer progression and chemoresistance.

Journal: Molecular cancer

Published: December 15, 2025

Compartmentalized branched-chain amino acid metabolism orchestrates colorectal cancer dissemination via an UMP-vimentin axis.

Compartmentalized branched-chain amino acid metabolism orchestrates colorectal cancer dissemination via an UMP-vimentin axis.

Journal: Cell metabolism

Published: September 23, 2025

Controlling the Oxidation State of Copper in Metal-Organic Frameworks for CO Electroreduction to Acetate.

Controlling the Oxidation State of Copper in Metal-Organic Frameworks for CO Electroreduction to Acetate.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: August 01, 2025

Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPK.

Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPK.

Journal: Cell host & microbe

Published: April 16, 2025

Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPK.

Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPK.

Journal: Cell host & microbe

Published: March 11, 2024

Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer.

Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer.

Journal: Frontiers in oncology

Published: December 30, 2022

The prospect of combination therapies with the third-generation EGFR-TKIs to overcome the resistance in NSCLC.

The prospect of combination therapies with the third-generation EGFR-TKIs to overcome the resistance in NSCLC.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 26, 2022

A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.

A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.

Journal: Frontiers in immunology

Published: April 27, 2022

Electrochemical Difunctionalization of Terminal Alkynes: Access to 1,4-Dicarbonyl Compounds.

Electrochemical Difunctionalization of Terminal Alkynes: Access to 1,4-Dicarbonyl Compounds.

Journal: Organic letters

Published: December 20, 2021

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.

Journal: Journal of hematology & oncology

Published: November 29, 2020

CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers.

CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers.

Journal: Expert opinion on investigational drugs

Published: August 22, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026